Current and historical daily PE Ratio for Alkem Laboratories Ltd (
NSE:ALKEM
) from 2015 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Alkem Laboratories stock (NSE:ALKEM) PE ratio as of May 24 2024 is 41.48.
More Details
Alkem Laboratories Ltd (NSE:ALKEM) PE Ratio (TTM) Chart
Alkem Laboratories Ltd (NSE:ALKEM) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1282
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Alkem Laboratories PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | 41.5 | 2024-03-25 | 36.4 |
| 2024-05-23 | 41.5 | 2024-03-22 | 36.4 |
| 2024-05-22 | 40.3 | 2024-03-21 | 36.5 |
| 2024-05-21 | 40.5 | 2024-03-20 | 36.4 |
| 2024-05-20 | 41.3 | 2024-03-19 | 37.0 |
| 2024-05-18 | 41.3 | 2024-03-18 | 37.8 |
| 2024-05-17 | 41.3 | 2024-03-15 | 38.4 |
| 2024-05-16 | 40.4 | 2024-03-14 | 37.9 |
| 2024-05-15 | 39.9 | 2024-03-13 | 37.6 |
| 2024-05-14 | 39.4 | 2024-03-12 | 38.4 |
| 2024-05-13 | 39.6 | 2024-03-11 | 39.2 |
| 2024-05-10 | 39.0 | 2024-03-08 | 39.1 |
| 2024-05-09 | 38.5 | 2024-03-07 | 39.1 |
| 2024-05-08 | 39.3 | 2024-03-06 | 39.6 |
| 2024-05-07 | 38.9 | 2024-03-05 | 38.8 |
| 2024-05-06 | 39.1 | 2024-03-04 | 39.0 |
| 2024-05-03 | 37.3 | 2024-03-01 | 38.9 |
| 2024-05-02 | 36.4 | 2024-02-29 | 39.0 |
| 2024-05-01 | 36.7 | 2024-02-28 | 37.9 |
| 2024-04-30 | 36.7 | 2024-02-27 | 38.3 |
| 2024-04-29 | 37.1 | 2024-02-26 | 38.5 |
| 2024-04-26 | 37.3 | 2024-02-23 | 41.2 |
| 2024-04-25 | 37.0 | 2024-02-22 | 41.2 |
| 2024-04-24 | 35.9 | 2024-02-21 | 41.2 |
| 2024-04-23 | 35.8 | 2024-02-20 | 41.1 |
| 2024-04-22 | 36.1 | 2024-02-19 | 41.6 |
| 2024-04-19 | 35.1 | 2024-02-16 | 41.4 |
| 2024-04-18 | 35.4 | 2024-02-15 | 40.4 |
| 2024-04-17 | 36.0 | 2024-02-14 | 39.8 |
| 2024-04-16 | 36.0 | 2024-02-13 | 40.2 |
| 2024-04-15 | 35.8 | 2024-02-12 | 39.1 |
| 2024-04-12 | 36.0 | 2024-02-09 | 40.5 |
| 2024-04-11 | 36.7 | 2024-02-08 | 40.4 |
| 2024-04-10 | 36.7 | 2024-02-07 | 39.0 |
| 2024-04-09 | 37.1 | 2024-02-06 | 38.5 |
| 2024-04-08 | 37.1 | 2024-02-05 | 37.4 |
| 2024-04-05 | 37.3 | 2024-02-02 | 37.4 |
| 2024-04-04 | 37.0 | 2024-02-01 | 36.9 |
| 2024-04-03 | 37.2 | 2024-01-31 | 38.0 |
| 2024-04-02 | 37.7 | 2024-01-30 | 37.6 |
| 2024-04-01 | 38.1 | 2024-01-29 | 37.8 |
| 2024-03-29 | 37.6 | 2024-01-26 | 37.8 |
| 2024-03-28 | 37.6 | 2024-01-25 | 37.8 |
| 2024-03-27 | 38.0 | 2024-01-24 | 38.0 |
| 2024-03-26 | 38.0 | 2024-01-23 | 36.6 |
Alkem Laboratories Ltd (NSE:ALKEM) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Alkem Laboratories Ltd
ISIN : INE540L01014
Compare
Compare
Traded in other countries / regions
ALKEM.India IPO Date
2015-12-23Description
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers